Liver-related outcomes in patients with cirrhosis: The value of clinical and laboratory data and noninvasive tests.
<h4>Background and purpose</h4>Cirrhosis patients face high mortality risks from complications, emphasizing the need for prognostic tools to estimate risk of adverse liver outcomes based on cirrhosis etiology and hence improve disease management. This study aimed to evaluate the associat...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0326702 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849320313099124736 |
|---|---|
| author | Somaya Albhaisi Amanda Robinson Rasha Alsaadawi Roy T Sabo Arun J Sanyal |
| author_facet | Somaya Albhaisi Amanda Robinson Rasha Alsaadawi Roy T Sabo Arun J Sanyal |
| author_sort | Somaya Albhaisi |
| collection | DOAJ |
| description | <h4>Background and purpose</h4>Cirrhosis patients face high mortality risks from complications, emphasizing the need for prognostic tools to estimate risk of adverse liver outcomes based on cirrhosis etiology and hence improve disease management. This study aimed to evaluate the association between baseline clinical factors, lab values and noninvasive measurements and risk of adverse liver outcomes among patients with cirrhosis, and develop disease-specific associative models.<h4>Methods</h4>Using proportional hazards regression, we developed six associative models, categorized by cirrhosis etiology, after identifying significant predictors of 30-day risk of ascites, hepatic encephalopathy (HE), and variceal bleeding (VB) among cirrhosis patients, with measurements selected through LASSO regression.<h4>Results</h4>A total of 4045 adult patients with cirrhosis were included in the analysis from a single U.S. center retrospective cohort. The 5-year rates for ascites, HE, and VB were 31.6%, 22.9%, and 30.7%, respectively. Multivariable analyses showed that independent predictors in cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) and viral hepatitis were: (a) ascites: albumin and international normalized ratio (INR); (b) HE: albumin, INR, total bilirubin, platelet count; (c) VB: albumin, platelet count, hemoglobin. No variables were significantly associated with outcomes in patients with alcohol-associated liver disease.<h4>Conclusions</h4>The newly developed models provided accurate estimates of the 30-day risks of ascites, HE, and VB in MASH or viral hepatitis-related cirrhosis using baseline variables, providing a reliable tool for identifying high-risk patients warranting intensified interventions. |
| format | Article |
| id | doaj-art-19a41c03a6e1471bb3bb2f2d87c633b9 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-19a41c03a6e1471bb3bb2f2d87c633b92025-08-20T03:50:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01207e032670210.1371/journal.pone.0326702Liver-related outcomes in patients with cirrhosis: The value of clinical and laboratory data and noninvasive tests.Somaya AlbhaisiAmanda RobinsonRasha AlsaadawiRoy T SaboArun J Sanyal<h4>Background and purpose</h4>Cirrhosis patients face high mortality risks from complications, emphasizing the need for prognostic tools to estimate risk of adverse liver outcomes based on cirrhosis etiology and hence improve disease management. This study aimed to evaluate the association between baseline clinical factors, lab values and noninvasive measurements and risk of adverse liver outcomes among patients with cirrhosis, and develop disease-specific associative models.<h4>Methods</h4>Using proportional hazards regression, we developed six associative models, categorized by cirrhosis etiology, after identifying significant predictors of 30-day risk of ascites, hepatic encephalopathy (HE), and variceal bleeding (VB) among cirrhosis patients, with measurements selected through LASSO regression.<h4>Results</h4>A total of 4045 adult patients with cirrhosis were included in the analysis from a single U.S. center retrospective cohort. The 5-year rates for ascites, HE, and VB were 31.6%, 22.9%, and 30.7%, respectively. Multivariable analyses showed that independent predictors in cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) and viral hepatitis were: (a) ascites: albumin and international normalized ratio (INR); (b) HE: albumin, INR, total bilirubin, platelet count; (c) VB: albumin, platelet count, hemoglobin. No variables were significantly associated with outcomes in patients with alcohol-associated liver disease.<h4>Conclusions</h4>The newly developed models provided accurate estimates of the 30-day risks of ascites, HE, and VB in MASH or viral hepatitis-related cirrhosis using baseline variables, providing a reliable tool for identifying high-risk patients warranting intensified interventions.https://doi.org/10.1371/journal.pone.0326702 |
| spellingShingle | Somaya Albhaisi Amanda Robinson Rasha Alsaadawi Roy T Sabo Arun J Sanyal Liver-related outcomes in patients with cirrhosis: The value of clinical and laboratory data and noninvasive tests. PLoS ONE |
| title | Liver-related outcomes in patients with cirrhosis: The value of clinical and laboratory data and noninvasive tests. |
| title_full | Liver-related outcomes in patients with cirrhosis: The value of clinical and laboratory data and noninvasive tests. |
| title_fullStr | Liver-related outcomes in patients with cirrhosis: The value of clinical and laboratory data and noninvasive tests. |
| title_full_unstemmed | Liver-related outcomes in patients with cirrhosis: The value of clinical and laboratory data and noninvasive tests. |
| title_short | Liver-related outcomes in patients with cirrhosis: The value of clinical and laboratory data and noninvasive tests. |
| title_sort | liver related outcomes in patients with cirrhosis the value of clinical and laboratory data and noninvasive tests |
| url | https://doi.org/10.1371/journal.pone.0326702 |
| work_keys_str_mv | AT somayaalbhaisi liverrelatedoutcomesinpatientswithcirrhosisthevalueofclinicalandlaboratorydataandnoninvasivetests AT amandarobinson liverrelatedoutcomesinpatientswithcirrhosisthevalueofclinicalandlaboratorydataandnoninvasivetests AT rashaalsaadawi liverrelatedoutcomesinpatientswithcirrhosisthevalueofclinicalandlaboratorydataandnoninvasivetests AT roytsabo liverrelatedoutcomesinpatientswithcirrhosisthevalueofclinicalandlaboratorydataandnoninvasivetests AT arunjsanyal liverrelatedoutcomesinpatientswithcirrhosisthevalueofclinicalandlaboratorydataandnoninvasivetests |